Month: October 2021

Jacques Cousteau defined a scientist as “… a curious man looking through the keyhole of nature, trying to know what's going on.” Nature has many mysteries. One of them concerns a possible connection between a man’s height and his risk of dying from prostate cancer... keep reading

In recent years, there’s been a huge shift in understanding the difference between insignificant and significant prostate cancer (PCa). Over 15 years ago, Albertsen, et al. (2005) established that clinically insignificant PCa could be defined as cancer that “will not affect the patient during the natural course of his lifetime. The indolent course of localised keep reading

“Limited attention has been given to the psychological impact of primary treatments in patients with prostate cancer.” We want to update our original post (below) about dementia/cognitive decline in relation to radical prostatectomy, by broadening it out to... keep reading

It was bad news then, and five years down the road it’s still bad news. According to Barnett, et al. (2021), “Of the risks associated with RT, the development of a secondary malignancy is of most concern for the patient and physician.” The blog we posted below presented a 2016 paper on prostate cancer radiation therapy as a catalyst for... keep reading

UPDATE: 10/26/2021 Originally published 7/7/2018 Dr. Snuffy Myers may be the world’s champion at durable remission of the prostate cancer (PCa). As a now-retired oncologist and survivor of the disease, he continues to lead, inspire and inform PCa patients. This update emphasizes Key Lifestyle Factor #4 in the original blog, Healthy Diet, based on a keep reading

Rising healthcare costs are even more concerning today than in 2014, when we posted the blog below. At the same time, advances in medical technology have continued at a steady pace. This is especially true for the ever-increasing applications of multiparametric MRI (mpMRI) in prostate cancer detection, diagnosis and treatment. keep reading

I have never met Dr. Bert Vorstman, a urologist in Coral Springs, FL, but he sounds like a doctor who is not afraid to speak his mind. In fact, he calls robotic prostate cancer surgery “a public health nightmare” and a “boondoggle for public health.” These are strong words, especially coming from a surgically-trained urologist... keep reading

Fourteen months prior to the time of this writing, the world began locking down due to the emerging SARS-CoV-2 viral pandemic and the potentially deadly COVID illness it causes. We were all confused, and studies repeatedly show that normal screening for cancers such as breast, prostate and colorectal dropped significantly... keep reading

Over the years, I have spoken with many patients about the idea of doctors being 100% open with regard to their treatment results. I came across a large-scaled Swedish study on prostatectomy side effects, and it’s as transparent as it gets. keep reading

Everyone has heard the term “chemotherapy” and it conjures up scary, negative images. On the other hand, have you heard the term “chemoprevention”? The National Cancer Institute defines chemoprevention as “the use of pharmacologic or natural agents that inhibit the development of invasive cancer... keep reading